Haven Capital Group’s AbbVie ABBV Stock Holding History

Haven Capital Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.57M	Buy	22,119 +280	+1%	+$60.2K	4.47%	8
2026 Q1	$4.75M	Buy	21,839 +248	+1%	+$55K	4.41%	6
2025 Q4	$4.93M	Buy	21,591 +30	+0.1%	+$6.83K	4.63%	6
2025 Q3	$4.99M	Sell	21,561 -233	-1%	-$47.4K	4.45%	6
2025 Q2	$4.04M	Sell	21,794 -605	-3%	-$112K	3.57%	10
2025 Q1	$4.69M	Sell	22,399 -647	-3%	-$126K	5.17%	7
2024 Q4	$4.1M	Buy	+23,046	New	+$4.24M	3.85%	8

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Haven Capital Group's ABBV Position: Q2 2026 in Review

Haven Capital Group increased its AbbVie (ABBV) stake by 1.3% in Q2 2026, buying an estimated $60.2K and bringing the position to 22,119 shares worth $5.57M. The position accounts for 4.47% of the portfolio, ranked #8.

Haven Capital Group first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Haven Capital Group held 22,119 shares of AbbVie worth $5.57M as of Q2 2026.
Haven Capital Group bought 280 AbbVie shares in Q2 2026, an estimated $60.2K.
AbbVie made up 4.47% of Haven Capital Group's portfolio in Q2 2026, its #8 holding.
Haven Capital Group first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Haven Capital Group's 13F filing for Q2 2026, filed 10 Jul 2026.